OBJECTIVE: It has been proposed that different stages of the bipolar disorder might have distinct neurobiological changes. However, the evidence for this has not been consistent, as the studies in early stages of the illness are limited by small sample sizes. The purpose of this study was to investigate the gray matter volume changes in bipolar patients who recently recovered from their first episode of mania (FEM). METHODS: Using a whole-brain voxel-based analysis, we compared the regional gray matter volumes of 61 bipolar patients who have recovered from their FEM in the past 3 months with 43 age- and gender-matched healthy participants. We also performed a series of subgroup analyses to determine the effects of hospitalization during the FEM, history of depressive episodes, and exposure to lithium. RESULTS: No statistically significant difference was found between gray matter volumes of FEM patients and healthy participants, even at a more liberal threshold (P < 0.001, uncorrected for multiple comparisons). Voxel-based subgroup analyses did not reveal significant gray matter differences except for a trend toward decreased gray matter volume in left lateral occipital cortex (P < 0.001, uncorrected) in patients with a previous history of depression. CONCLUSION: This study represents the largest structural neuroimaging investigation of FEM published to date. Early stage of bipolar disorder was not found to be associated with significant gray matter volume changes. Our findings suggest that there might be a window of opportunity for early intervention strategies to prevent or delay neuroprogression in bipolar disorder.
OBJECTIVE: It has been proposed that different stages of the bipolar disorder might have distinct neurobiological changes. However, the evidence for this has not been consistent, as the studies in early stages of the illness are limited by small sample sizes. The purpose of this study was to investigate the gray matter volume changes in bipolarpatients who recently recovered from their first episode of mania (FEM). METHODS: Using a whole-brain voxel-based analysis, we compared the regional gray matter volumes of 61 bipolarpatients who have recovered from their FEM in the past 3 months with 43 age- and gender-matched healthy participants. We also performed a series of subgroup analyses to determine the effects of hospitalization during the FEM, history of depressive episodes, and exposure to lithium. RESULTS: No statistically significant difference was found between gray matter volumes of FEM patients and healthy participants, even at a more liberal threshold (P < 0.001, uncorrected for multiple comparisons). Voxel-based subgroup analyses did not reveal significant gray matter differences except for a trend toward decreased gray matter volume in left lateral occipital cortex (P < 0.001, uncorrected) in patients with a previous history of depression. CONCLUSION: This study represents the largest structural neuroimaging investigation of FEM published to date. Early stage of bipolar disorder was not found to be associated with significant gray matter volume changes. Our findings suggest that there might be a window of opportunity for early intervention strategies to prevent or delay neuroprogression in bipolar disorder.
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Caleb M Adler; Melissa P DelBello; Kelly Jarvis; Ari Levine; John Adams; Stephen M Strakowski Journal: Biol Psychiatry Date: 2006-10-06 Impact factor: 13.382
Authors: Marguerite Reid Schneider; Melissa P DelBello; Robert K McNamara; Stephen M Strakowski; Caleb M Adler Journal: Bipolar Disord Date: 2012-06 Impact factor: 6.744
Authors: M Berk; F Kapczinski; A C Andreazza; O M Dean; F Giorlando; M Maes; M Yücel; C S Gama; S Dodd; B Dean; P V S Magalhães; P Amminger; P McGorry; G S Malhi Journal: Neurosci Biobehav Rev Date: 2010-10-08 Impact factor: 8.989
Authors: Lakshmi N Yatham; Marcia Kauer-Sant'Anna; David J Bond; Raymond W Lam; Ivan Torres Journal: Can J Psychiatry Date: 2009-02 Impact factor: 4.356
Authors: D P Hibar; L T Westlye; N T Doan; N Jahanshad; J W Cheung; C R K Ching; A Versace; A C Bilderbeck; A Uhlmann; B Mwangi; B Krämer; B Overs; C B Hartberg; C Abé; D Dima; D Grotegerd; E Sprooten; E Bøen; E Jimenez; F M Howells; G Delvecchio; H Temmingh; J Starke; J R C Almeida; J M Goikolea; J Houenou; L M Beard; L Rauer; L Abramovic; M Bonnin; M F Ponteduro; M Keil; M M Rive; N Yao; N Yalin; P Najt; P G Rosa; R Redlich; S Trost; S Hagenaars; S C Fears; S Alonso-Lana; T G M van Erp; T Nickson; T M Chaim-Avancini; T B Meier; T Elvsåshagen; U K Haukvik; W H Lee; A H Schene; A J Lloyd; A H Young; A Nugent; A M Dale; A Pfennig; A M McIntosh; B Lafer; B T Baune; C J Ekman; C A Zarate; C E Bearden; C Henry; C Simhandl; C McDonald; C Bourne; D J Stein; D H Wolf; D M Cannon; D C Glahn; D J Veltman; E Pomarol-Clotet; E Vieta; E J Canales-Rodriguez; F G Nery; F L S Duran; G F Busatto; G Roberts; G D Pearlson; G M Goodwin; H Kugel; H C Whalley; H G Ruhe; J C Soares; J M Fullerton; J K Rybakowski; J Savitz; K T Chaim; M Fatjó-Vilas; M G Soeiro-de-Souza; M P Boks; M V Zanetti; M C G Otaduy; M S Schaufelberger; M Alda; M Ingvar; M L Phillips; M J Kempton; M Bauer; M Landén; N S Lawrence; N E M van Haren; N R Horn; N B Freimer; O Gruber; P R Schofield; P B Mitchell; R S Kahn; R Lenroot; R Machado-Vieira; R A Ophoff; S Sarró; S Frangou; T D Satterthwaite; T Hajek; U Dannlowski; U F Malt; V Arolt; W F Gattaz; W C Drevets; X Caseras; I Agartz; P M Thompson; O A Andreassen Journal: Mol Psychiatry Date: 2017-05-02 Impact factor: 15.992
Authors: Anderson M Winkler; Gerard R Ridgway; Matthew A Webster; Stephen M Smith; Thomas E Nichols Journal: Neuroimage Date: 2014-02-11 Impact factor: 6.556